The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Brian F. Gage

MSc, Washington University School of Medicine

Campus Box 8005

660 S. Euclid Ave

[email]@im.wustl.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • MSc, Washington University School of Medicine, Campus Box 8005, 660 S. Euclid Ave. 2001 - 2011
  • Washington University Medical Center, St Louis, MO 63110, USA. 2008
  • Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. 2008

References

  1. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation. Shah, S.V., Gage, B.F. Circulation (2011) [Pubmed]
  2. Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. Gage, B.F., Lesko, L.J. J. Thromb. Thrombolysis (2008) [Pubmed]
  3. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Gage, B.F., Eby, C., Johnson, J.A., Deych, E., Rieder, M.J., Ridker, P.M., Milligan, P.E., Grice, G., Lenzini, P., Rettie, A.E., Aquilante, C.L., Grosso, L., Marsh, S., Langaee, T., Farnett, L.E., Voora, D., Veenstra, D.L., Glynn, R.J., Barrett, A., McLeod, H.L. Clin. Pharmacol. Ther. (2008) [Pubmed]
  4. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Gage, B.F., Birman-Deych, E., Radford, M.J., Nilasena, D.S., Binder, E.F. Arch. Intern. Med. (2006) [Pubmed]
  5. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Gage, B.F., Yan, Y., Milligan, P.E., Waterman, A.D., Culverhouse, R., Rich, M.W., Radford, M.J. Am. Heart J. (2006) [Pubmed]
  6. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Gage, B.F., Birman-Deych, E., Kerzner, R., Radford, M.J., Nilasena, D.S., Rich, M.W. Am. J. Med. (2005) [Pubmed]
  7. Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements. Gage, B.F., Milligan, P.E. Thromb. Res. (2005) [Pubmed]
  8. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. Gage, B.F., Eby, C., Milligan, P.E., Banet, G.A., Duncan, J.R., McLeod, H.L. Thromb. Haemost. (2004) [Pubmed]
  9. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Gage, B.F., van Walraven, C., Pearce, L., Hart, R.G., Koudstaal, P.J., Boode, B.S., Petersen, P. Circulation (2004) [Pubmed]
  10. Pharmacogenetics and anticoagulant therapy. Gage, B.F., Eby, C.S. J. Thromb. Thrombolysis (2003) [Pubmed]
  11. Warfarin therapy for an octogenarian who has atrial fibrillation. Gage, B.F., Fihn, S.D., White, R.H. Ann. Intern. Med. (2001) [Pubmed]
  12. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Gage, B.F., Waterman, A.D., Shannon, W., Boechler, M., Rich, M.W., Radford, M.J. JAMA (2001) [Pubmed]
 
WikiGenes - Universities